The horizontal layer is built.
What's missing is the vertical depth.

Datasite has spent the last eighteen months building one of the clearest deal‑intelligence platform plays in the market. Grata, Sourcescrub, Blueflame, and now Valu8 closed the breadth, geographic, and AI‑workflow axes. The complementary axis — vertical depth in the single largest M&A vertical by deal value — is the one Galen Growth has spent eleven years building.

The strategic role. HealthTech Alpha is the trusted healthcare ontology and evidence layer required for AI‑native sourcing, diligence, and transaction workflows — the vertical complement to Grata's horizontal coverage, Valu8's European depth, and Datasite's recently opened AI ecosystem (MCP Server, Legora, Blueflame). It could convert Datasite from an M&A workflow platform into a fully end‑to‑end investment and commercial process enabler in healthcare — extending reach upstream to the deal‑sourcing origin point and downstream into pharma, payer, and institutional‑investor decision workflows.

The value anchor — replication effort, not ARR multiple. Replicating Galen Growth today is not a software build. It is a multi‑year undertaking (5–7 years) requiring substantial capital and coordinated execution across proprietary data, evidence‑linked ontology, expert validation, and global commercial traction. On a fully burdened basis, recreating a comparable asset would likely require on the order of $50M to $75M of cumulative investment, with no assurance of achieving equivalent depth, credibility, or market position within that timeframe. The central risk is execution, not just cost — whether the semantic infrastructure and the market trust that sits on top of it can be assembled at all in today's environment. The Galen Growth principals are explicitly flexible on transaction structure and terms; the conversation is about alignment with Datasite's long‑term value‑creation thesis.

The intelligence axis Datasite has built

Sourcing

Grata · Sourcescrub · Valu8

Intelligence

16M+ companies · 220k sources

Vertical depth

Galen Growth — Healthcare

AI workflow

Blueflame · MCP Server · Legora

Execution

Diligence · Acquire · Prepare

Galen Growth slots in as the vertical semantic layer underneath the existing horizontal intelligence — and brings named healthcare‑vertical leadership into the intelligence stack.

The strategic numbers

CapVest commitment

$500M

Announced with Grata, June 2025. Explicitly organic and inorganic. Blueflame, Sourcescrub, and Valu8 have consumed part — meaningful capacity remains.

Galen Growth coverage

17,000+

Digital‑health ventures tracked across 100+ countries. >1.5B structured & unstructured data points. Evidence‑linked digital‑health ontology, evidence‑graded.

Pharma M&A rank

Largest M&A vertical by deal value globally. Healthcare & Life Sciences is one of Datasite Forecaster's named content franchises.

Replication effort

$50–75M

Cumulative, fully‑burdened investment over 5–7 years to recreate the asset — with no guarantee of equivalent depth, credibility, or market position. Execution risk, not just cost.

What the horizontal stack reaches — and what it can't

What Grata + Sourcescrub + Valu8 reach

~16M+ companies via 220k+ information sources
Website‑crawl + ML taxonomy (generic by design)
Strong middle‑market US coverage breadth
European financial depth (Valu8)
PE / search‑fund / corporate‑development sales channel
AI‑native, integrates with Blueflame, MCP Server, Legora

What it can't produce — and what Galen Growth provides

Evidence‑linked digital‑health ontology — not inferable from crawls or financials
Entity resolution across companies, programs, pipelines, partnerships
Evidence grading — peer‑reviewed clinical evidence vs. marketing claims
Evidence lineage that AI agents can cite back to source
Therapeutic category, regulatory pathway, reimbursement context
Eleven years of human curation across 17,000+ digital‑health ventures
Pharma / medical‑device / payer / health‑system customer base
Named healthcare‑vertical leadership inside the intelligence stack

Build alternative is execution risk, not just cost — a 5–7 year, $50M–$75M fully‑burdened effort with no guarantee of equivalent depth, credibility, or market position.

An integration template Datasite has already executed

Grata operates as a strategic business unit inside Datasite. Andrew Bocskocsky (GM, Data & Intelligence) and Nevin Raj (GM, Grata) lead it. Sourcescrub was folded into Grata in 2025; Valu8 was folded in via the same template in May 2026 — preserving the data‑layer brands while Datasite remains the workflow brand.

We'd suggest Galen Growth could fit the same template. HealthTech Alpha would be preserved as the vertical‑depth brand. Leadership would be retained. No Datasite product‑team bandwidth would be reallocated. Galen Growth's data would plug into Datasite Forecaster's healthcare content engine. The Grata sales channel — PE, search funds, corporate development — would gain a vertical product to upsell. Galen Growth's principals would step into the named healthcare‑vertical leadership role.

Grata + Sourcescrub + Valu8 gave Datasite horizontal breadth and geographic depth. Galen Growth offers Datasite the vertical depth in the one M&A vertical where breadth and geography alone are not credible to the buyer — and where Datasite already hosts the largest customer relationships. — Kane & Company strategic rationale

The competitive position

SS&C Intralinks	AI feature investments but no Grata‑equivalent intelligence acquisition. The vertical‑depth move widens the workflow‑intelligence moat against them.
Ansarada · Firmex	No intelligence layer at all. Not a competitive threat in this play.
PitchBook	Horizontal and weak on digital health specifically and on evidence‑graded data generally. Acquiring Galen Growth is a flank attack in the highest‑value vertical without requiring a horizontal contest.
CB Insights · Crunchbase	Narrative‑driven and shallower. No vertical healthcare depth at the Galen Growth level.

Galen Growth — the company

Founded	2015, Singapore. Eleven years of operating history.
Platform	HealthTech Alpha — AI‑driven SaaS. 17,000+ digital‑health companies. 100+ countries. >1.5B structured & unstructured data points.
Differentiators	Evidence‑linked digital‑health ontology. Evidence grading. Entity resolution across companies / programs / pipelines / partnerships. Eleven years of human curation.
Customer base	Top‑tier pharma, medical device, payer, insurer, health system, institutional investor, strategy consultancy. Commercial traction achieved through an intentionally lean go‑to‑market model — significant operating leverage available to a buyer with global commercial reach.
Platform portability	The data layer is platform‑portable — proven in commercial distribution outside the Galen Growth platform. Detail available on request.

A 30‑minute conversation

The detailed Internal Rationale Memo — written as source material for Datasite leadership to use internally — is ready to share on request. The first conversation can start with Nevin Raj and Andrew Bocskocsky on platform fit and Pallavi Pal on Grata product fit.

Reply to Michael Kane →

The horizontal layer is built.What's missing is the vertical depth.